期刊文献+

中医药治疗高血压心肌纤维化机制的研究进展

Research Progress of Mechanism of Traditional Chinese Medicine in Treating Hypertensive Myocardial Fibrosis
下载PDF
导出
摘要 高血压引起的心肌纤维化改变是一个多因素、多机制作用的过程,对心室扩张、心力衰竭的发生发展具有重要意义。中医药治疗高血压心肌纤维化临床疗效明显,机制研究也取得了一定的成果,为了进一步探讨中医药治疗高血压心肌纤维化的机制及研究方向,将近年来应用于临床及实验研究的中药单体及复方根据作用机制进行简要综述,为中医药治疗高血压心肌纤维化提供理论参考。 The change of myocardial fibrosis caused by hypertension is a multi-factor and multi-mechanism process, which is of great significance for the development of ventricular dilatation and heart failure. The clinical efficacy of traditional Chinese medicine in the treatment of hypertensive myocardial fibrosis is obvious. The mechanism research has also achieved certain results. In order to further explore the mechanism and research direction of treating hypertensive myocardial fibrosis with traditional Chinese medicine, the action mechanism of the traditional Chinese medicine monomers and compounds used in clinical and experimental research in recent years were briefly reviewed, which provides the theory reference for treating hypertensive myocardial fibrosis with traditional Chinese medicine .
出处 《大众科技》 2019年第6期80-83,共4页 Popular Science & Technology
基金 国家自然科学基金项目(81160437) 2011卫生厅重点课题(重2011058)
关键词 高血压心肌纤维化 中医药 机制 研究进展 hypertensive myocardial fibrosis traditional Chinese medicine mechanism research progress
  • 相关文献

参考文献12

二级参考文献102

  • 1丁绍祥.原发性高血压发病机制及治疗探讨[J].航空航天医学杂志,2009,21(10):30-32. 被引量:22
  • 2张明国,光雪峰.细胞凋亡在心血管疾病中的研究[J].医学综述,2004,10(8):470-471. 被引量:4
  • 3张本静,王焱林,王成夭.参附注射液对缺氧/复氧损伤心肌核因子-κB及肿瘤坏死因子-α、白介素-6的影响[J].中华急诊医学杂志,2007,16(1):42-45. 被引量:14
  • 4Gary AJ,Park PW.The mitogenic effects of the B beta chain of fibrinogen,mediated through cell surface calreticulin[J].Biol Chem,1995,270(44):26 602-26606.
  • 5Yang M, Zheng J, Miao YJ, et al. Serum-Glucocorticoid regulated Kinase 1 regulates alternatively activated macrophage polarization con-tributing to angiotensin Ⅱ-induced inflammation and cardiac fibrosis [J]. Arterioseler Thromb Vase Biol,2012,32(7) :1675-1686.
  • 6Berk BC, Fujiwara K, Lehoux S, et al. ECM remodeling in hy pertensive heart disease[J]. J Clin Invest, 2007,117(3 ) : 568-575.
  • 7Shiojima I, Sato K, Izumiya Y, et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure[J]. J Clin Invest,2005,115(8) : 2108-2118.
  • 8Braz JC, Gill RM, Corbly AK, et al. Selective activation of PI3Kalpha/Akt/GSK-3beta signalling and cardiac compensatory hypertrophy during recovery from heart failure[J]. Eur J Heart Fail, 2009,11 (8) : 739-748.
  • 9Xu R, IAn F, Zhang S, et al. Signal pathways involved in reverse remodeling of the hypertrophic rat heart after pressure unloading [J]. Int J Cardiol,2010,143(3):414-423.
  • 10Diniz GP, Carneiro-ramos MS, Barreto-chaves MI., et al. Angio- tensin type 1 receptor mediates thyroid hormone-induced cardio- myocyte hypertrophy through the Akt/GSK 3heta/mTOR signa ling pathway[J]. Basic Res Cardiol, 2009,104 ( 6 ) : 653-667.

共引文献395

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部